RT Journal Article
T1 Patient-Reported Outcome Measures in Real-World Atopic Dermatitis Studies in Spain: A Systematic Review.
T2 Medidas de los resultados percibidos por el paciente en estudios de vida real en dermatitis atópica en España: revisión sistemática de la literatura.
A1 Armario-Hita, J C
A1 Artime, E
A1 Vidal-Vilar, N
A1 Huete, T
A1 Díaz-Cerezo, S
A1 Moro, R M
A1 Lizán, L
A1 Frutos, F J Ortiz de
K1 Atopic dermatitis
K1 Calidad de Vida relacionada con la salud
K1 Dermatitis Atópica
K1 Estudios observacionales
K1 Health-related quality of life
K1 Medidas de los resultados percibidos por el paciente
K1 Observational studies
K1 Patient-reported outcome measures
K1 Pruritis
K1 Prurito
K1 Symptoms
K1 Síntomas
AB Atopic dermatitis (AD) is a chronic inflammatory skin disease with symptoms such as pruritus that can be a major burden for patients. Patient-reported outcomes (PRO) complement clinician-reported outcomes in AD. This systematic review aims to identify and describe patient-reported outcome measures (PROM) used in observational studies of AD over the last decade in Spain. Eighteen PROM were identified to measure 13 different PRO that assess multiple aspects of the disease, including symptoms and disease severity, impact on daily activities and on work productivity/functioning, psychosocial impact, patient empowerment, and health-related quality of life (HRQoL). HRQoL, symptoms (particularly pruritus), and anxiety/depression were the most frequently assessed PRO, and the Dermatology Quality of Life Index, the Visual Analogue Pruritus Scale, and the Hospital Anxiety and Depression Scale were the most frequently used PROM, respectively. The growing number of observational studies on AD including PROM in Spain suggests that PRO are becoming increasingly important in the management of AD.
YR 2022
FD 2022-02-10
LK http://hdl.handle.net/10668/21870
UL http://hdl.handle.net/10668/21870
LA en
LA es
DS RISalud
RD May 12, 2025